EUVIMEDEUVIMED entdecken
Querschnittstudie

Epidemiological analysis of kidney involvement in systemic lupus erythematosus using the national database of designated intractable diseases of Japan: a cross-sectional study of renewal applicants

Hidekazu Ikeuchi, Tomonori Kimura, Shoichi Maruyama, Yoshitaka Isaka, Ichiei Narita, Keiju Hiromura

Clinical and Experimental Nephrology · 2026-07 · 30 (7) · 987-997

DOI: 10.1007/s10157-026-02863-4 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Clinical and Experimental Nephrology, online erschienen am 07.04.2026. Verfasst von Hidekazu Ikeuchi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Rheumatology, Gunma University Graduate School of Medicine, 3-39-22 Showa, Maebashi, Gunma, 371-8511, Japan. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Lupus Nephritis. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Ministry of Health, Labour and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To estimate the prevalence of active kidney involvement and its associations with comorbidities and treatment patterns among patients with systemic lupus erythematosus (SLE) at renewal application for the Designated Intractable Diseases of Japan. METHODS: We analyzed Medical Certificates of Designated Intractable Diseases that were submitted in 2016 for the renewal of SLE designation. Among 35,207 digitized patients (mean age, 51.1 ± 15.7 years), active kidney involvement was defined as proteinuria (≥ 0.5 g/day) and/or urinary casts (granular casts or red blood cell casts) recorded as Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) items during the 6 months preceding the renewal application. RESULTS: Active kidney involvement was identified in 8273 patients (23.5%). Compared with those without active kidney involvement, patients with active kidney involvement had a younger mean age at disease onset (32.6 ± 15.3 vs. 34.1 ± 15.2 years) and a lower proportion of females (84.3% vs. 90.5%). They more frequently had comorbid infection (14.6% vs. 10.6%), diabetes mellitus (16.2% vs. 11.2%), and hypertension (43.6% vs. 25.6%), and had higher disease activity (mean SLEDAI, 14.8 ± 9.4 vs. 7.0 ± 6.4). Glucocorticoid use was more common (94.9% vs. 91.8%), fewer patients received ≤ 7.5 mg/day (45.9% vs. 59.2%), and concomitant immunosuppressant use was higher (60.8% vs. 44.1%). CONCLUSION: Approximately one-quarter of Japanese patients with SLE undergoing renewal had active kidney involvement, which was associated with higher disease activity, more comorbidities (notably hypertension), and greater use of glucocorticoid and immunosuppressants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicLupus NephritisHumansFemaleJapanCross-Sectional StudiesAdultMaleMiddle AgedDatabases, FactualPrevalenceComorbidityAgedImmunosuppressive AgentsYoung AdultProteinuriaAge of OnsetRisk Factors

Stichwörter der Autor:innen

GlucocorticoidKidney involvementNational databaseSystemic lupus erythematosus

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Nephrology and Rheumatology, Gunma University Graduate School of Medicine, 3-39-22 Showa, Maebashi, Gunma, 371-8511, Japan.
  • Department of Nephrology, The University of Osaka Graduate School of Medicine, Suita, Japan.
  • Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Division of Clinical Nephrology and Rheumatology, Kidney Research Center, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Department of Nephrology and Rheumatology, Gunma University Graduate School of Medicine, 3-39-22 Showa, Maebashi, Gunma, 371-8511, Japan. hiromura@gunma-u.ac.jp.

Förderung

  • Ministry of Health, Labour and Welfare

Zitieren

APA

Ikeuchi, H., Kimura, T., Maruyama, S., Isaka, Y., Narita, I., & Hiromura, K. (2026). Epidemiological analysis of kidney involvement in systemic lupus erythematosus using the national database of designated intractable diseases of Japan: a cross-sectional study of renewal applicants. Clinical and Experimental Nephrology, 30(7), 987-997. https://doi.org/10.1007/s10157-026-02863-4

Vancouver

Ikeuchi H, Kimura T, Maruyama S, Isaka Y, Narita I, Hiromura K. Epidemiological analysis of kidney involvement in systemic lupus erythematosus using the national database of designated intractable diseases of Japan: a cross-sectional study of renewal applicants. Clinical and Experimental Nephrology. 2026;30(7):987-997. doi:10.1007/s10157-026-02863-4

BibTeX
@article{Ikeuchi2026,
  author = {Ikeuchi, Hidekazu and Kimura, Tomonori and Maruyama, Shoichi and Isaka, Yoshitaka and Narita, Ichiei and Hiromura, Keiju},
  title = {Epidemiological analysis of kidney involvement in systemic lupus erythematosus using the national database of designated intractable diseases of Japan: a cross-sectional study of renewal applicants},
  journal = {Clinical and Experimental Nephrology},
  year = {2026},
  volume = {30},
  number = {7},
  pages = {987--997},
  doi = {10.1007/s10157-026-02863-4}
}
Kostenlos starten →